6 October 2020 in Cancer Discovery
Glioblastoma is a universally lethal cancer driven by glioblastoma stem cells (GSC). Here, we interrogated N6-methyladenosine (m6A) mRNA modifications in GSCs by methyl RNA immunoprecipitation followed by sequencing and transcriptome analysis, finding transcripts marked by m6A often upregulated compared with normal neural stem cells (NSC). Interrogating m6A regulators, GSCs displayed preferential expression, as well as in vitro and in vivo dependency, of the m6A reader YTHDF2, in contrast to NSCs. Although YTHDF2 has been reported to destabilize mRNAs, YTHDF2 stabilized MYC and VEGFA transcripts in GSCs in an m6A-dependent manner. We identified IGFBP3 as a downstream effector of the YTHDF2–MYC axis in GSCs. The IGF1/IGF1R inhibitor linsitinib preferentially targeted YTHDF2-expressing cells, inhibiting GSC viability without affecting NSCs and impairing in vivo glioblastoma growth. Thus, YTHDF2 links RNA epitranscriptomic modifications and GSC growth, laying the foundation for the YTHDF2–MYC–IGFBP3 axis as a specific and novel therapeutic target in glioblastoma.Significance: Epitranscriptomics promotes cellular heterogeneity in cancer. RNA m6A landscapes of cancer and NSCs identified cell type–specific dependencies and therapeutic vulnerabilities. The m6A reader YTHDF2 stabilized MYC mRNA specifically in cancer stem cells. Given the challenge of targeting MYC, YTHDF2 presents a therapeutic target to perturb MYC signaling in glioblastoma.This article is highlighted in the In This Issue feature, p. 211
29 March 2019 in Nature Communications
Dengue (DENV) and Zika (ZIKV) viruses are clinically important members of the Flaviviridae family with an 11 kb positive strand RNA genome that folds to enable virus function. Here, we perform structure and interaction mapping on four DENV and ZIKV strains inside virions and in infected cells. Comparative analysis of SHAPE reactivities across serotypes nominates potentially functional regions that are highly structured, conserved, and contain low synonymous mutation rates. Interaction mapping by SPLASH identifies many pair-wise interactions, 40% of which form alternative structures, suggesting extensive structural heterogeneity. Analysis of shared interactions between serotypes reveals a conserved macro-organization whereby interactions can be preserved at physical locations beyond sequence identities. We further observe that longer-range interactions are preferentially disrupted inside cells, and show the importance of new interactions in virus fitness. These findings deepen our understanding of Flavivirus genome organization and serve as a resource for designing therapeutics in targeting RNA viruses.
20 January 2023 in Science
Multicellular life requires altruistic cooperation between cells. The adaptive immune system is a notable exception, wherein germinal center B cells compete vigorously for limiting positive selection signals. Studying primary human lymphomas and developing new mouse models, we found that mutations affecting BTG1 disrupt a critical immune gatekeeper mechanism that strictly limits B cell fitness during antibody affinity maturation. This mechanism converted germinal center B cells into supercompetitors that rapidly outstrip their normal counterparts. This effect was conferred by a small shift in MYC protein induction kinetics but resulted in aggressive invasive lymphomas, which in humans are linked to dire clinical outcomes. Our findings reveal a delicate evolutionary trade-off between natural selection of B cells to provide immunity and potentially dangerous features that recall the more competitive nature of unicellular organisms.
23 October 2025 in bioRxiv
SUMMARY: A central concept in epitranscriptomics is that the RNA demethylase FTO acts as a site-selective eraser of N 6 -methyladenosine (m 6 A) in specific mRNAs. This is most well-established in acute myeloid leukemia (AML), where demethylation of MYC is thought to promote leukemogenesis. Using nanopore direct RNA sequencing to quantify m 6 A transcriptome-wide, we find that m 6 A stoichiometry, including at MYC -specific sites, remains unaffected by FTO knockdown or pharmacologic inhibition in AML. Conversely, levels of N 6 -2’-O-dimethyladenosine (m 6 Am) are markedly increased in snRNAs, indicating that m 6 Am, not m 6 A, is the major substrate of FTO in AML. We extend these results outside the AML context in FTO knockout brain and HEK293T cells, detecting no selective increases in mRNA m 6 A but widespread increases in snRNA m 6 Am levels following FTO depletion. These findings suggest that FTO has minimal ability to erase m 6 A in mRNA. Instead, the reported biological effects of FTO are likely mediated by demethylation of m 6 Am.
16 December 2021 in bioRxiv
N 6 -methyladenosine (m 6 A) is a highly prevalent mRNA modification which promotes degradation of transcripts encoding proteins that have roles in cell development, differentiation, and other pathways. METTL3 is the major methyltransferase that catalyzes the formation of m 6 A in mRNA. As 30–80% of m 6 A can remain in mRNA after METTL3 depletion by CRISPR/Cas9-based methods, other enzymes are thought to catalyze a sizable fraction of m 6 A. Here, we re-examined the source of m 6 A in the mRNA transcriptome. We characterized mouse embryonic stem cell lines which continue to have m 6 A in their mRNA after Mettl3 knockout. We show that these cells express alternatively spliced Mettl3 transcript isoforms that bypass the CRISPR/Cas9 mutations and produce functionally active methyltransferases. We similarly show that other reported METTL3 knockout cell lines express altered METTL3 proteins. We find that gene dependency datasets show that most cell lines fail to proliferate after METTL3 deletion, suggesting that reported METTL3 knockout cell lines express altered METTL3 proteins rather than have full knockout. Finally, we reassessed METTL3’s role in synthesizing m 6 A using a genomic deletion of Mettl3 , and found that METTL3 is responsible for >95% of m 6 A in mRNA. Overall, these studies suggest that METTL3 is responsible for the vast majority of m 6 A in the transcriptome, and that remaining m 6 A in putative METTL3 knockout cell lines is due to the expression of altered but functional METTL3 isoforms.